Bucyrus: Analysts' Upgrades, Downgrades
Editor's Note: Green and red arrows refer to intraday stock price movement.
NEW YORK (
) --
CHANGE IN RATINGS
AthenaHealth
(ATHN) - Get Report
downgraded at FBR from Outperform to Market Perform. Valuation call, based on a $44 price target.
Blackrock
(BLK) - Get Report
rated new Outperform at Wells Fargo. Company is an industry leader, but the stock has underperformed its peers year-to-date.
Biomarin
(BMRN) - Get Report
downgraded at UBS from Buy to Neutral. Valuation call, based on a $28 price target.
Bucyrus
( BUCY) downgraded at Goldman from Buy to Neutral.
CVR Energy
(CVI) - Get Report
upgraded at Goldman to Buy. Refining market is improving.
Itron
(ITRI) - Get Report
rated new Sell at Goldman Sachs. $45 price target. Company will likely lose market share in the next several quarters.
Jo-Ann Stores
( JAS) estimates raised at Credit Suisse. JAS 2011 and 2012 EPS estimate increased to $3.44 and $3.82, respectively. Solid 3Q results, but earnings growth slowing as expected, Credit Suisse said. Maintain Neutral rating and $47 price target.
Legg Mason
(LM) - Get Report
rated new Market Perform at Wells Fargo. Company still faces challenges to growth.
Stifel Financial
(SF) - Get Report
upgraded at Goldman from Neutral to Buy. The company's wealth management business is a beneficiary of better capital markets activity.
Southwest Gas
(SWX) - Get Report
downgraded at Argus from Buy to Hold. Valuation call, as the stock has gained 15% over the past three months.
This article was written by a staff member of TheStreet.